Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients - Wikidata - wikimedia - TriplyDB

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients

http://www.wikidata.org/entity/Q24810778

about

A two-stage meta-analysis identifies several new loci for Parkinson's disease Quantitative assessment of the effect of FGF20 rs12720208 variant on the risk of Parkinson's disease: a meta-analysis.FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.Genetic variation in FGF20 modulates hippocampal biology Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein Genetics of Parkinson disease and essential tremor The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease.Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.Roles of FGF20 in dopaminergic neurons and Parkinson's disease.Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson's diseases: a meta-analysis.Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease

P2860

Q21144948-CD47A3B5-1E46-4C16-9187-D18864787295 Q30238475-6DF77B84-781D-4106-8C1B-D5248AC205B5 Q33873286-BB3A8142-A0F8-4F01-A1DE-25CC72A36A11 Q34018828-4AC9324E-5355-4A99-9845-8D31E8AB2BA7 Q36718966-87B1A80B-4F37-4F1A-B609-6FFB19C60735 Q37594762-91438C6B-25CF-46B9-B743-ECF8CD503166 Q37642802-CD32F40B-DD75-4CD4-9F12-2A02E1CA0604 Q38381823-9B6C093D-293B-460E-A374-120920AB0E26 Q41237490-745EB1F1-00C5-407E-8766-D09147DFB0AC Q53149543-374E597D-510E-40AD-B0B6-05DA4F6E0A1A Q57619872-DB28A1C8-037B-4A5A-8100-216657342E60

P2860

Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients

http://www.wikidata.org/entity/Q24810778

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Lack of evidence for a genetic ...... in Finnish and Greek patients

@ast

Lack of evidence for a genetic ...... in Finnish and Greek patients

@en

Lack of evidence for a genetic ...... in Finnish and Greek patients

@nl

type

label

Lack of evidence for a genetic ...... in Finnish and Greek patients

@ast

Lack of evidence for a genetic ...... in Finnish and Greek patients

@en

Lack of evidence for a genetic ...... in Finnish and Greek patients

@nl

prefLabel

Lack of evidence for a genetic ...... in Finnish and Greek patients

@ast

Lack of evidence for a genetic ...... in Finnish and Greek patients

@en

Lack of evidence for a genetic ...... in Finnish and Greek patients

@nl

P1433

Q24810778-3FB9ED18-0D9D-41E6-A3F1-72338EB1875B

P1476

Q24810778-DC90A8A8-3619-4190-9417-FBCFBE74B84B

P2093

Q24810778-2EE8A49F-AB9F-4AAF-A645-D6F985793949

Q24810778-36D3B57E-FC21-4672-A928-9A3A33DB7265

Q24810778-48168F1E-D4FA-450C-8927-44FB4C9BE311

Q24810778-52BFDA4A-B98F-444E-B80A-6266BAA34B13

Q24810778-72FEA435-C7F3-474C-A1F2-87352D13273F

Q24810778-8D8F141C-2702-427B-88A8-CA073DE54130

Q24810778-A6BF143E-A953-4F1D-874E-83B26237B28F

Q24810778-A77F746E-700E-4D41-BA51-2B63D08FF739

Q24810778-F0CB3D9B-2254-4408-B87E-D6401FFCA465

Q24810778-F626D02B-4F1D-40F7-A0F5-19BCCF7AB99C

P2860

Q24810778-029AA7A1-8D56-4266-A827-F574590ED8B4

Q24810778-08057D38-5850-402A-93B6-81E91D511ED3

Q24810778-42796275-6EEB-4C02-82E9-130D8F9735B6

Q24810778-55FBB96E-331A-4825-AEAA-B903C83D056F

Q24810778-6CC3C087-39AA-4209-84C3-1341DB041417

Q24810778-796F9F88-48A2-4352-A8D4-1764E7DC2ACF

Q24810778-8776C7F7-9EB0-445F-B00E-E53D3E960FFA

Q24810778-A0243960-447B-4C1C-AA30-B886BB680FA2

Q24810778-B9D10D59-B686-4700-BB5A-91B0CBE35F14

Q24810778-C4FE8565-C906-4007-B832-D6CCC5CF3856

P2888

Q24810778-6E0DEACA-F358-4ED1-820D-DC9E2EC40DA1

P304

Q24810778-778EAB04-DD9F-41EE-9023-B79DA64B1C1A

P31

Q24810778-F36C603A-89CF-466C-8987-CD3A388D5C34

P356

Q24810778-F3038B0C-8D46-44ED-B64B-A8E9CA9A2194

P407

Q24810778-D9D5F394-57E5-4021-9EBD-47C297F7AA59

P433

Q24810778-F3BF9CDB-FEC2-4822-871A-BEDC562FCC12

P478

Q24810778-F089A98F-B044-44D5-944D-4F6679EFCF7E

P50

Q24810778-02A470E5-9201-49EB-8830-940F386CD3D6

Q24810778-49BA931B-C1AC-4DFD-9A8F-A69A7C3835C1

P577

Q24810778-D9F240F5-CCBB-4310-9F9A-D393B0B3C3F1

P5875

Q24810778-10C241D8-730E-44BB-903B-B3AEE6B944E3

P6179

Q24810778-3D577A8E-3383-423E-B541-05C1E6AB3284

P698

Q24810778-2A5AADFB-5D7E-4E7C-A658-81C5B516CA47

P921

Q24810778-37F6086F-3EAB-4505-90CA-D3CD7ED1CE59

Q24810778-C3624860-22CA-4AC1-83D8-9F977F4374D3

P932

Q24810778-857A3C43-1CA6-4CB4-A254-D0BC09724E70

P356

P1433

P1476

Lack of evidence for a genetic ...... in Finnish and Greek patients

@en

P2093

Alexandros Papadimitriou

http://www.w3.org/2001/XMLSchema#string

Euthimios Dardiotis

http://www.w3.org/2001/XMLSchema#string

George M Hadjigeorgiou

http://www.w3.org/2001/XMLSchema#string

Georgia Xiromerisiou

http://www.w3.org/2001/XMLSchema#string

Johanna Eerola

http://www.w3.org/2001/XMLSchema#string

Jordi Clarimon

http://www.w3.org/2001/XMLSchema#string

Olli Hellström

http://www.w3.org/2001/XMLSchema#string

Pentti J Tienari

http://www.w3.org/2001/XMLSchema#string

Terhi Peuralinna

http://www.w3.org/2001/XMLSchema#string

Vanesa Gourbali

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain

Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.

Genetics of parkinsonism.

Genes and parkinsonism.

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease.

Complete genomic screen in Parkinson disease: evidence for multiple genes.

P2888

P304

11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2377-5-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Georgia Xiromerisiou

Andrew Singleton

P577

2005-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7776452

http://www.w3.org/2001/XMLSchema#string

P6179

1013453376

http://www.w3.org/2001/XMLSchema#string

P698

15967032

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

1183215

http://www.w3.org/2001/XMLSchema#string